TMC's Center for Liver Disease Management and Transplantation (CLDMT) is a specialized clinic with an existing program for liver cancer. It is composed of a highly trained, multidisciplinary team of experts involved in the care of patients with malignant liver disease. Treatment options for all stages (early, intermediate, advanced) of liver cancer are available at the CLDMT.
These include surgery (liver resection, liver transplantation), local ablation (radiofrequency ablation [RFA], microwave ablation, percutaneous ethanol injection [PEI]), locoregional therapy (Transarterial Chemoembolization [TACE], Drug-eluting Bead Chemoembolization [DEB-TACE], Selective Internal Radiation Therapy [SIRT] with Yttrium90 beads), systemic therapy (chemotherapy, molecular targeted therapy, biologic agents) and palliative care. The CLDMT is likewise actively involved in viral hepatitis and liver cancer research, both locally and internationally.
Treatment: Surgery, Local Ablation, Locoregional Therapy, Drug-eluting Bead Chemoembolization, Selective Internal Radiation Therapy, Systemic therapy, and palliative care